Sign in
CompletedNo phase

Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Status
Completed
People taking part
5 people enrolled
Started
22 Sept 2021
Ended
28 May 2024
Type of study
Interventional
Treatments tested
  • the Terumo Hydropearl® microspheres device
Record updated
4 November 2024

Who can take part

Age
40 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • We intend to include patients who meet the following criteria in the study:
  • Patients aged 40-80
  • Bilateral or Unilateral knee pain attributed to osteoarthritis
  • Grade 1-3 Osteoarthritis as diagnosed on standing weight-bearing knee radiographs per the Kellen-Lawrence Grading scale
  • Knee pain >6 months refractory to conservative medical management (NSAIDs, paracetamol, intra-articular injections, physiotherapy/exercise, weight loss, etc.)

Who cannot take part

  • We plan to exclude patients who meet any of the following criteria:; Active malignancy; Active infection of the affected knee; Platelets <50,000; INR >1.8 (unless on anticoagulation that can be reversed); Corticosteroid injection of the affected knee within 3 months; Rheumatoid arthritis or other seronegative arthropathy; Previous surgery (excluding arthroscopy) of the affected knee; Grade 4 per Kellgren-Lawrence Grading Scale of the affected knee; Pregnancy or expected pregnancy; GFR <30; Anaphylactic reaction to iodinated contrast; Moderate to severe pain in other lower limb joints; Body weight >400 lbs. (Procedure table weight limit); BMI >50; Patients at high risk for contrast nephropathy

Where in United States

  • University of Chicago HospitalChicago, United States

About the trial

What the trial wants to find out

The goal of this study is to perform a feasibility study to show the effectiveness of the genicular artery embolization procedure in reducing bilateral or unilateral osteoarthritic knee pain at 12 months as measured by WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score, Knee Injury and Osteoarthritis Outcome (KOOS) score, and Oswestry Disability Index.

The group in the trial

  • GAE ArmTreatment being tested

    Patients who meet study eligibility will be scheduled to undergo the Genicular Artery Embolization procedure and will subsequent be followed for 12 months after their procedure.

    Treatment: the Terumo Hydropearl® microspheres device

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis: A Pilot Study to Assess Feasibility
Record updated
4 November 2024